Racial Alchemy
By Osagie K. Obasogie,
Bioethics Forum
| 05. 18. 2007
Bioethics and the Skin Tone Gene
Since the 2005 discovery that the SLC24A5 gene variant plays a sizable role in human skin pigmentation, scientists have become increasingly intrigued by the possibility of genetically manipulating skin color. Curiously, however, this research is going on with little mention of the dreaded “R” word: race.
A recent New Scientist article, for example, expends almost 3,000 words on the ins and outs of skin color’s genetic basis and apparent malleability without once mentioning race. The author eagerly notes, however, that “our skin color might one day become almost as easy to change as hair color is today, freeing us from the constraints of our genes [and] mak[ing] life far harder for those who still insist on judging people on the basis of a handful of gene variants.” Nina Jablonski’s 2006 book Skin: A Natural History devotes nearly 300 pages to understanding skin’s social, cultural, and biological significance without seriously engaging race’s long and tortured history; only two references to race appear in its index.
It is not uncommon for scientists to underestimate race’s relevance to their work. Stanford geneticist Gregory...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...